Technology
Adaptive Bioelectronic and Biopharmaceutical Technologies.
Aurealix develops conceptual architectures that combine adaptive neurocartography, physiological state modelling, uncertainty-aware reasoning, transition mapping and longitudinal model evaluation.
Platform structure
Two pillars.
One integrated
architecture.
The Aurealix technology position is organized around two complementary pillars. The bioelectronic pillar focuses on neurocartography, adaptive neuromodulation and stimulation systems with spatiotemporal activation patterns and response-phase logic. The biopharmaceutical pillar focuses on probabilistic in vivo delivery, proteostasis, tipping points and hazard-function based control.
Pillar I
Bioelectronics and neurocartography.
Adaptive bioelectronic concepts for personalized neuromodulation, multimodal sensing and historically learning functional neurocartography.
- Bioelectronic systems and sensing
- Functional neurocartography
- Spatiotemporal activation patterns
- Response-phase logic and adaptive feedback
Pillar II
Probabilistic biopharmaceutical control.
Probabilistic architectures for adaptive in vivo release, proteostasis instability modelling and tipping-point based therapeutic optimization.
- Probabilistic in vivo delivery
- Adaptive therapeutics
- Proteostasis and tipping-point models
- Hazard functions for release decisions
Aurealix Innovation Notes
Aurealix Innovation Frameworks.
Six complementary scientific frameworks structure the Aurealix approach to functional mapping, peripheral interpretation, state representation, uncertainty-aware reasoning, transition modelling and long-term physiological reorganization.
AFN
Adaptive Functional Neurocartography.
Maps individualized functional response regions and response landscapes.
APIM
Adaptive Peripheral Intent Mapping.
Interprets peripheral physiological signals as functional intent and context.
NSPP
Neurophysiological State Stabilization and Proteostasis Preservation.
Represents and anticipates neurophysiological states relevant to stabilization and proteostasis preservation.
BNPSS
Bioelectronic Neurocartography for Proteostasis State Stabilization.
Supports uncertainty-aware physiological reasoning under incomplete, noisy or variable information.
STM
Sensorimotor Transition Mapping.
Models transitions between functional and neurophysiological states and supports transition-sensitive reasoning.
APR
Adaptive Physiological Reorganization.
Addresses long-term physiological reorganization, model validity, drift and evidence-bounded recalibration.
Shared core
Multitemporal, uncertainty-aware and continuously refined.
Across both pillars, the common architecture is based on multimodal observation, historical evidence, probabilistic reasoning, transition modelling, outcome evaluation and bounded model updating. The implementation may differ by domain: bioelectronic interaction in MedTech and adaptive physiological substance delivery in Biopharma.
IP position
Patent-pending portfolio.
Aurealix is supported by a portfolio of fifteen patent filings focused on adaptive bioelectronic systems, neurocartographic knowledge models, probabilistic physiological control and adaptive therapeutic architectures.
Collaboration
Validation partners welcome.
Aurealix is seeking dialogue with academic, clinical, technology and industrial partners interested in validation, platform development and translational pathways.